PVP Ventures accepts CEO and COO resignations effective September 24

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • PVP Ventures accepted resignations of CEO Ellen Jane Feehan and COO Neeraja Nagarajan effective September 24, 2026
  • Feehan cited unavoidable personal health reasons for not joining the company
  • Nagarajan resigned due to non-alignment with the incoming CEO and leadership style differences
  • Both executives held roles as Executive Directors in addition to their operational titles
  • Disclosures made under Regulation 30 of SEBI (LODR) Regulations, 2015
powered bylight_fuzz_icon
51793771

*this image is generated using AI for illustrative purposes only.

PVP Ventures has accepted the resignation of Dr. Ellen Jane Feehan as Executive Director and Chief Executive Officer, and Dr. Neeraja Nagarajan as Executive Director and Chief Operating Officer. Both departures are effective September 24, 2026.

Leadership change at PVP Ventures

The simultaneous exit of the top two executive officers marks a significant leadership development for the company. Dr. Ellen Jane Feehan tendered her resignation citing unavoidable personal health reasons. In her communication, she stated she was unable to take up the assignment offered under an Executive Employment Agreement dated July 1, 2026, and would not join on October 1, 2026.

Dr. Neeraja Nagarajan resigned due to the non-alignment of Dr. Ellen Feehan as CEO, with whom she was expected to synergize. Her resignation letter cited differentials in leadership styles, cultures, and operating models, alongside domicile requirements related to family in the United States.

Regulatory disclosures

The company informed stock exchanges under Regulation 30 read with Clause 7(C) of Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015. Prasad V. Potluri, Chairman and Managing Director of PVP Ventures, signed the official communication to the National Stock Exchange of India Limited and BSE Limited.

Detail Information
Company PVP Ventures
Executive 1 Dr. Ellen Jane Feehan
Position 1 Executive Director & CEO
Development 1 Resignation
Date of Cessation 1 September 24, 2026
Reason 1 Personal health reasons
Executive 2 Dr. Neeraja Nagarajan
Position 2 Executive Director & COO
Development 2 Resignation
Date of Cessation 2 September 24, 2026
Reason 2 Leadership misalignment

The filing noted that detailed communications from both directors were enclosed as annexures to the disclosure. The company's registered office is located in Chennai, with corporate offices in Hyderabad.

Historical Stock Returns for PVP Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
+3.21%-10.56%-22.08%+30.18%+57.64%0.0%

Who will be appointed as the interim CEO and COO to bridge the leadership gap before permanent replacements are secured?

How might the simultaneous exit of the top two executives impact PVP Ventures' ongoing strategic initiatives and operational continuity?

What are the potential implications for investor confidence and stock price volatility following this significant management reshuffle?

PVP Ventures closes trading window ahead of Q2FY27 results

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • PVP Ventures Ltd closed its trading window effective October 1, 2026
  • The window remains closed until 48 hours after Q2FY27 results declaration
  • Closure applies to designated persons, relatives, and insiders per SEBI regulations
  • Board meeting date for reviewing standalone and consolidated results to be announced later
powered bylight_fuzz_icon
52227266

*this image is generated using AI for illustrative purposes only.

PVP Ventures Ltd has closed its trading window for all designated persons, their immediate relatives, and insiders effective October 1, 2026. The closure will remain in force until 48 hours after the declaration of the company's unaudited financial results for the quarter and half year ended September 30, 2026.

Regulatory compliance details

The decision was taken pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015. It also complies with the company's Code of Conduct for Prevention of Insider Trading. The restriction applies to dealing in securities of the company during this period.

Board meeting schedule

The date for the Board Meeting to consider the unaudited standalone and consolidated financial results for Q2FY27 and H1FY27 will be intimated in due course. No specific date was disclosed in the current notification.

Detail Information
Company PVP Ventures Ltd
Window Closure Start October 1, 2026
Window Closure End 48 hours post-results declaration
Results Period Quarter and half year ended September 30, 2026
Signatory Prasad V. Potluri, Chairman and Managing Director

This procedural step ensures that no insider information regarding the upcoming financial performance is utilized for trading purposes before it becomes public knowledge.

Historical Stock Returns for PVP Ventures

1 Day5 Days1 Month6 Months1 Year5 Years
+3.21%-10.56%-22.08%+30.18%+57.64%0.0%

What are the anticipated market reactions if PVP Ventures' Q2FY27 results deviate significantly from analyst consensus?

How might the delay in announcing the specific board meeting date impact investor sentiment and trading volumes for PVP Ventures?

Are there any pending regulatory filings or corporate actions by PVP Ventures that could coincide with the upcoming financial results declaration?

More News on PVP Ventures

1 Year Returns:+57.64%